Mobia Medical to Report Q3 Results on November 5
Stroke survivors using the Vivistim system may learn more about the manufacturer's performance during the upcoming update.
Updated on Oct. 15, 2026 in Stroke
Live Poll
Is now a good time to evaluate your investments based on quarterly earnings reports?
Mobia Medical, the manufacturer of the Vivistim Paired VNS System for stroke survivors with upper limb impairments, will release its third quarter 2026 financial results on November 5, 2026. The company will also host a conference call and webcast to discuss the results at 4:30 p.m. ET that day.
Why it matters
Understanding the financial trajectory of device manufacturers can provide insight into the long-term support and availability of specialized medical technologies. For stroke survivors utilizing or considering the Vivistim system, these updates may offer context on the company's operational stability.
The company has scheduled its third quarter 2026 financial report for November 5, 2026, comparing current operations against previous fiscal periods. Specific revenue and growth data regarding the Vivistim Paired VNS System remain unknown until the report is published.
The players
Mobia Medical
A medical device company headquartered in Austin that develops the Vivistim Paired VNS System for stroke rehabilitation.
The details
Mobia Medical produces the Vivistim Paired VNS System, which is designed to help stroke survivors manage and potentially improve upper limb motor impairments. The device utilizes targeted vagus nerve stimulation to pair rehabilitation exercises with electrical impulses to the nerve, aiming to promote neural plasticity. The upcoming conference call will allow company management to update stakeholders on the device's market reach and institutional adoption.
Timeline
November 5, 2026: Financial results announcement and conference call at 4:30 p.m. ET.
Health Landscape
The market for neurological rehabilitation devices has expanded as more advanced neurostimulation tools like the Vivistim Paired VNS System emerge. This financial reporting event provides a look at the commercial integration of such technologies into standard stroke care pathways.
Stroke survivors who use or are considering the Vivistim Paired VNS System may want to follow this report to understand the device's market presence. Clinical questions regarding the compatibility of this system with your current recovery plan are always worth discussing with your doctor.
The takeaway
Keeping track of financial developments can help you understand the long-term viability of specific medical device manufacturers. If you are exploring specialized rehabilitation technologies for stroke recovery, consult with your physician to see if these tools align with your personal care plan.
What happens next
Mobia Medical will host its third quarter 2026 conference call and webcast on November 5, 2026, at 4:30 p.m. ET.
Further reading
For more information on current treatment trends for stroke recovery, visit Stroke.
Live Poll
Is now a good time to evaluate your investments based on quarterly earnings reports?
